J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, F. Bray (2014). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer doi:10.1002/ijc.29210 PMID:25220842 Published online 9 October 2014.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. doi:10.1002/ijc.29210. Epub 2014 Oct 9.
Office for National Statistics. Ethnicity and National Identity in England and Wales 2011. London: Office for National Statistics; 2012. Available at: http://www.ons.gov.uk/ons/rel/census/2011-census/key-statistics-for-local-authorities-in-england-and-wales/rpt-ethnicity.html.
Hossain A, Hogan TF, Rahman R, Hobbs G. Survival Disparities in Bladder, Kidney, and Prostate Cancer in Asian-Indian & Pakistani Immigrants to the United States as Compared to Other US Ethnic Groups: A Surveillance, Epidemiology and End Result (SEER) 2011 Public Use Database Study. Cancer Clin Oncol. 2013;2(1).
Udayaraj U, Ben-Shlomo Y, Roderick P, Casula A, Dudley C, Johnson R, et al. Social deprivation, ethnicity, and access to the deceased donor kidney transplant waiting list in England and Wales. Transplantation. 2010;90(3):279–85.
Parkin DM, Khlat M. Studies of cancer in migrants: rationale and methodology. Eur J Cancer. 1996;32A(5):761–71.
Morris M, Woods LM, Rogers N, O’Sullivan E, Kearins O, Rachet B. Ethnicity, deprivation and screening: survival from breast cancer among screening-eligible women in the West Midlands diagnosed from 1989 to 2011. Br J Cancer. 2015;113(3):548–55.
Winter H, Cheng KK, Cummins C, Maric R, Silcocks P, Varghese C. Cancer incidence in the south Asian population of England (1990-92). Br J Cancer. 1999;79(3-4):645–54.
Smith LK, Peake MD, Botha JL. Recent changes in lung cancer incidence for south Asians: a population based register study. BMJ. 2003;326(7380):81–2.
Rastogi T, Devesa S, Mangtani P, Mathew A, Cooper N, Kao R, et al. Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int J Epidemiol. 2008;37(1):147–60.
Ethnic group statistics: a guide for the collection and classification of ethnicity data.: Office for National Statistics. 2003 http://www.ons.gov.uk/ons/guide-method/measuring-equality/equality/measuring-equality--a-guide/ethnicgroup-statistics--a-guide-for-the-collection-and-classification-of-ethnicity-data.pdf.
Mathur R, Bhaskaran K, Chaturvedi N, Leon DA, VanStaa T, Grundy E, et al. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health (Oxf). 2014;36(4):684–92.
The NHS Information Centre. How good is HES ethnic coding and where do the problems lie? 2011http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=171.
Ali R, Barnes I, Cairns BJ, Finlayson AE, Bhala N, Mallath M, et al. Incidence of gastrointestinal cancers by ethnic group in England, 2001-2007. Gut. 2012;62:1692–703.
Shirley MH, Sayeed S, Barnes I, Finlayson A, Ali R. Incidence of haematological malignancies by ethnic group in England, 2001-7. Br J Haematol. 2013;163(4):465–77.
Shirley MH, Barnes I, Sayeed S, Finlayson A, Ali R. Incidence of breast and gynaecological cancers by ethnic group in England, 2001-2007: a descriptive study. BMC Cancer. 2014;14:979. doi:10.1186/1471-2407-14-979.
World Health Organization. International Statistical Classification of Diseases and Related Health Outcomes , 10th Revision. Geneva: World Health Organization; 1992.
World Health Organization. International Classification of Diseases for Oncology, 3rd Revision. Geneva: World Health Organization; 2000.
World Health Organization. International Classification for Diseases of Oncology, 2nd Revision. Geneva: World Health Organization; 1990.
Noble M, McLennan D, Wilkinson K, Whitworth A, Barnes H, Dibben C. The English Indices of Deprivation 2007. London: Communities and Local Government; 2008.
Segi M. Cancer Mortality for Selected Sites in 24 Countries (1950-57). Sendai: Department of Public Health, Tohoku University of Medicine; 1960.
Easton DF, Peto J, Babiker AG. Floating absolute risk - an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med. 1991;10:1025–35.
Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.
Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol. 2008;179(5):1704–8.
Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer. 2005;114:101–8.
Sproston K, Mindell J. Health Survey for England 2004. The health of minority ethnic groups. London: The Stationery Office; 2006.
Lipworth L, McLaughlin JK, Tarone RE, Blot WJ. Renal cancer paradox: higher incidence but not higher mortality among African-Americans. Eur J Cancer Prev. 2011;20(4):331–3.
Forman D. Cancer Incidence and Survival by Major Ethnic Group, England, 2002–2006. London: National Cancer Intelligence Network; 2009.
Morrison AS, Buring JE, Verhoek WG, Aoki K, Leck I, Ohno Y, et al. An international study of smoking and bladder cancer. J Urol. 1984;131(4):650–4.
Sun CL, Yuan JM, Arakawa K, Low SH, Lee HP, Yu MC. Dietary soy and increased risk of bladder cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1674–7.
Jack RH, Davies EA, Møller H. Testis and prostate cancer incidence in ethnic groups in South East England. Int J Androl. 2007;30(4):215–20.
Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer. 2005;116:331–9.
McGlynn KA, Graubard BI, Klebanoff MA, Longnecker MP. Risk factors for cryptorchism among populations at differing risks of testicular cancer. Int J Epidemiol. 2006;35:787–95.
Merrill RM, Sloan A. Risk-adjusted incidence rates for prostate cancer in the United States. Prostate. 2012;72(2):181–5.
Wells TS, Bukowinski AT, Smith TC, Smith B, Dennis LK, Chu LK, et al. Racial differences in prostate cancer risk remain among US servicemen with equal access to care. Prostate. 2010;70(7):727–34.
Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, et al. The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. Eur Urol. 2008;53(1):99–105.
Mordukhovich I, Reiter PL, Backes DM, Family L, McCullough LE, O’Brien KM, et al. A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer causes control. 2011;22(3):341–57.
Hayes RB, Ziegler RG, Gridley G, Swanson C, Greenberg RS, Swanson GM, et al. Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev. 1999;8(1):25–34.
Hatcher D, Daniels G, Osman I, Lee P. Molecular mechanisms involving prostate cancer racial disparity. Am J Transl Res. 2009;1(3):235–48.
Mason TE, Ricks-Santi L, Chen W, Apprey V, Joykutty J, Ahaghotu C, et al. Association of CD14 variant with prostate cancer in African American men. Prostate. 2010;70(3):262–9.
Whitman EJ, Pomerantz M, Chen Y, Chamberlin MM, Furusato B, Gao C, et al. Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy. Cancer Epidemiol Biomarkers Prev. 2010;19(1):1-8. doi: 10.1158/1055-9965.EPI-08-1111.
Hooker S, Bonilla C, Akereyeni F, Ahaghotu C, Kittles RA. NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans. Prostate Cancer Prostatic Dis. 2008;11(4):349–56.
Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet. 2011;43(6):570–3.
Jack RH, Davies EA, Møller H. Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England. BJU Int. 2010;105(9):1226–30.
Metcalfe C, Patel B, Evans S, Ibrahim F, Anson K, Chinegwundoh F, et al. The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study. BJU Int. 2008;102(10):1407–12.
Harding S, Rosato M. Cancer incidence among first generation Scottish, Irish, West Indian and South Asian migrants living in England and Wales. Ethn Health. 1999;4(1-2):83–92.
Wild SH, Fischbacher CM, Brock A, Griffiths C, Bhopal R. Mortality from all cancers and lung, colorectal, breast and prostate cancer by country of birth in England and Wales, 2001-2003. Br J Cancer. 2006;94(7):1079–85.
Maringe C, Mangtani P, Rachet B, Leon DA, Coleman MP, dos Santos SI. Cancer incidence in South Asian migrants to England, 1986-2004: unraveling ethnic from socioeconomic differentials. Int J Cancer. 2013;132(8):1886–94.
Hamson C, Goh L, Sheldon P, Samanta A. Comparative study of bone mineral density, calcium, and vitamin D status in the Gujarati and white populations of Leicester. Postgrad Med J. 2003;79:279–83.
John EM, Koo J, Schwartz GG. Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev. 2007;16:1283–6.
Chan J, Giovannucci E, Andersson S, Yuen J, Adami H, Wolk A. Dairy products, calcium, phosphorous, vitamin d, and risk of prostate cancer (Sweden). Cancer Causes Control. 1998;9(6):559–66.
Chan J, Stampfer M, Ma J, Gann P, Gaziano J, Giovannucci E. Dairy products, calcium, and prostate cancer risk in the physicians’ health study. Am J Clin Nutri. 2001;74(4):549–54.
Peinta K, Esper P. Risk factors for prostate cancer. Ann Intern Med. 1993;118(10):793–803.
Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KG et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ. 1999;319:215–20.
Rundle A, Jankowski M, Kryvenko ON, Tang D, Rybicki BA. Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate. Cancer Epidemiol Biomarkers Prev. 2013;22(5):898–904.
Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, Hsing AW. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 2003;12(7):665–8.